Rapport Therapeutics, Inc.

NasdaqGM:RAPP Stock Report

Market Cap: US$373.0m

Rapport Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:RAPP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Mar 25BuyUS$100,988Troy IgnelziIndividual10,000US$10.10
12 Mar 25BuyUS$61,250Wendy YoungIndividual6,000US$10.21
01 Jul 24BuyUS$1,079,575Synergy Capital LimitedCompany44,032US$26.06
10 Jun 24BuyUS$8,316,910Sofinnova Investment, Inc.Company489,230US$17.00
10 Jun 24BuyUS$1,183,098Synergy Capital LimitedCompany69,594US$17.00

Insider Trading Volume

Insider Buying: RAPP insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RAPP?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,304,1795.54%
Hedge Funds2,940,9217.07%
VC/PE Firms16,326,83439.2%
Institutions20,047,85948.2%

Dilution of Shares: RAPP only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 109.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
22.2%
Third Rock Ventures, LLC
8,104,451US$82.8m0%27.67%
15%
FMR LLC
5,486,468US$56.1m0%no data
10.2%
Arch Venture Partners, L.P.
3,728,738US$38.1m0%2.77%
8.06%
Cormorant Asset Management, LP
2,940,921US$30.1m0%2.35%
7.19%
T. Rowe Price Group, Inc.
2,625,133US$26.8m-5.58%no data
7.13%
Capital Research and Management Company
2,602,529US$26.6m0%no data
6.84%
Johnson & Johnson Innovation - JJDC, Inc.
2,498,051US$25.5m0%8.09%
5.47%
Sofinnova Investment, Inc.
1,995,594US$20.4m0%1.5%
3.41%
Goldman Sachs Group, Investment Banking and Securities Investments
1,244,310US$12.7m-0.63%0.01%
3.2%
BlackRock, Inc.
1,167,251US$11.9m54.3%no data
3.06%
The Vanguard Group, Inc.
1,115,424US$11.4m101%no data
3.04%
AllianceBernstein L.P.
1,109,625US$11.3m1.02%no data
2.69%
Goldman Sachs Asset Management, L.P.
980,730US$10.0m0%no data
2.16%
Abraham Ceesay
789,705US$8.1m0%no data
1.31%
Steven Paul
477,642US$4.9m0%no data
1.26%
David Bredt
460,642US$4.7m-1.81%no data
1.25%
Deep Track Capital, LP
457,556US$4.7m0%0.16%
1.04%
Artal Group S.A.
378,469US$3.9m-1.49%0.13%
0.86%
Geode Capital Management, LLC
315,663US$3.2m49.8%no data
0.8%
Swamy Yeleswaram
290,831US$3.0m0%no data
0.68%
Citadel Advisors LLC
249,414US$2.5m-48.8%no data
0.64%
Broad Street Principal Investments, L.L.C.
233,735US$2.4m0%1.59%
0.57%
Logos Global Management, L.P.
208,910US$2.1m0%0.36%
0.53%
Ensign Peak Advisors, Inc.
194,200US$2.0m0%no data
0.52%
State Street Global Advisors, Inc.
191,122US$2.0m14.1%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/20 12:25
End of Day Share Price 2025/05/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Rapport Therapeutics, Inc. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason ButlerCitizens JMP Securities, LLC
Salveen RichterGoldman Sachs
Lin TsaiJefferies LLC